Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Physical Review Letters
|
January 15, 2011
Ultrafast melting of a charge-density wave in the Mott insulator 1T-TaS2
S Hellmann, M Beye, C Sohrt, et al.
AIDS (London, England)
|
October 9, 2002
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, et al.
AIDS (London, England)
|
February 19, 2005
A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, et al.
The Journal of Infectious Diseases
|
June 25, 2004
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection
Jason D Barbour, Frederick M Hecht, Terri Wrin, et al.
The Journal of Infectious Diseases
|
March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
The Journal of Infectious Diseases
|
January 25, 2002
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy
Steven G Deeks, Rebecca Hoh, Robert M Grant, et al.
AIDS (London, England)
|
April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors
C A Kemper, M D Witt, P H Keiser, et al.
The New England Journal of Medicine
|
August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIV
Susan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Virology
|
October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites
A J Brown, H M Precious, J M Whitcomb, et al.
JAMA
|
September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
S J Little, E S Daar, R T D'Aquila, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Physical Review Letters
|
January 15, 2011
Ultrafast melting of a charge-density wave in the Mott insulator 1T-TaS2
S Hellmann, M Beye, C Sohrt, et al.
AIDS (London, England)
|
October 9, 2002
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, et al.
AIDS (London, England)
|
February 19, 2005
A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, et al.
The Journal of Infectious Diseases
|
June 25, 2004
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection
Jason D Barbour, Frederick M Hecht, Terri Wrin, et al.
The Journal of Infectious Diseases
|
March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
The Journal of Infectious Diseases
|
January 25, 2002
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy
Steven G Deeks, Rebecca Hoh, Robert M Grant, et al.
AIDS (London, England)
|
April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors
C A Kemper, M D Witt, P H Keiser, et al.
The New England Journal of Medicine
|
August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIV
Susan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Virology
|
October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites
A J Brown, H M Precious, J M Whitcomb, et al.
JAMA
|
September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
S J Little, E S Daar, R T D'Aquila, et al.
Page
of 6